当前位置: 首页 > 期刊 > 《新医学》 > 20206
编号:13473745
LS7综合干预对预防心房颤动患者射频消融术后复发的价值(5)
http://www.100md.com 2020年6月1日 《新医学》 20206
     [13] Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, Alonso A. Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol, 2014, 7(4):620-625.

    [14] Ogunmoroti O, Michos ED, Aronis KN, Salami JA, Blankstein R, Virani SS, Spatz ES, Allen NB, Rana JS, Blumenthal RS, Veledar E, Szklo M, Blaha MJ, Nasir K. Life’s simple 7 and the risk of atrial fibrillation: the multi-ehnic study of atherosclerosis. Atherosclerosis, 2018, 275:174-181.

    [15] Koyama T, Sekiguchi Y, Tada H, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto M, Sugi-yasu A, Kuga K, Aonuma K. Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation. Am J Cardiol, 2009, 103(9):1249-1254.

    [16] McCabe JM, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE, Marcus GM. Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin Electro-physiol, 2008, 31(9):1146-1151.

    [17] Zhang Y, Chen A, Song L, Li M, Chen Y, He B. Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation. Int Heart J, 2016, 57(2):183-189.

    (收稿日期:2020-02-21)

    (本文編辑:林燕薇), 百拇医药(刘君 赖俊 张晓雪 何咏聪 冷梅芳 胡婷婷 叶泽兵)
上一页1 2 3 4 5